Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Mylan announced a global collaboration with Gilead Sciences to expand access to the investigational antiviral remdesivir for the potential treatment of COVID-19.
read more
Mylan Chairman Robert J. Coury and Chief Executive Officer Heather Bresch provided additional detail regarding the company's efforts to meet public health needs amid the evolving COVID-19 pandemic.
read more
Monday, December 04, 2017
Mylan and Aspen announced the U.S. launch of Myleran Injection, 60 mg/10 mL (6 mg/mL) Single-dose Vial, a generic version of Busulfex Injection.
read more
Mylan and Lupin announced that the EC has granted marketing authorization for Nepexto, a biosimilar to Enbrel.
read more
Tuesday, December 22, 2020
Nabriva has announced the restructuring of its license agreement with Sinovant for XENLETA in the greater China region.
read more
Monday, September 25, 2017
Jaguar Health announced its wholly-owned subsidiary, Napo Pharmaceuticals, has entered into a Termination, Asset Transfer and Transition Agreement with India-based Glenmark Pharmaceuticals.
read more
Tuesday, February 20, 2024
National Resilience, Inc. (Resilience) announced the expansion of the company’s clinical and commercial drug product manufacturing capabilities across its network. By scaling this capacity, Resilience aims to provide over 200 million units to its ...
read more
Tuesday, September 01, 2020
The NCCN Oncology Research Program announced plans to develop a program to scientifically evaluate and facilitate clinical trials on the efficacy of decitabine and cedazuridine.
read more
Wednesday, October 18, 2017
goBalto announced its latest release of goBalto Activate.
read more
Nitto Denko Avecia announced the opening of its new oligonucleotide API manufacturing facility in Milford, MA.
read more
Tuesday, November 05, 2024
NJ Bio, Inc. and Charles River Laboratories, Inc. announced a strategic alliance to offer complementary services to clients including early development and optimization to manufacturing of antibody drug conjugates (ADCs).
read more
Noramco and SPI Pharma have signed an agreement to develop and license a set of “value-added” formulation packages for global pharmaceutical manufacturers of finished dosage forms.
read more
The Noramco Group, an integrated North American-based API and drug product supply chain product and services provider, announced a $25 million investment in its Halo Pharma facility in Whippany, New Jersey, to establish sterile injectable ...
read more
Noramco and AFC announced a strategic partnership to produce certain US DEA controlled substances for use in the treatment of addiction, abuse prevention, cannabinoids for clinical indications, and ADHD.
read more
Novadoz has received FDA approval for their generic versions of Oseltamivir Phosphate Capsules and Dofetilide Capsules.
read more